Vanguard Portfolio Management
RCUS icon

Vanguard Portfolio Management’s Arcus Biosciences RCUS Stock Holding History

Vanguard Portfolio Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138M Buy
4,475,528
+203,472
+5% +$5.03M 0.01% 1378
2026
Q1 		$92.3M Buy
+4,272,056
New +$92.3M ﹤0.01% 1461

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management's RCUS Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Arcus Biosciences (RCUS) stake by 4.8% in Q2 2026, buying an estimated $5.03M and bringing the position to 4,475,528 shares worth $138M. The position accounts for 0.01% of the portfolio, ranked #1378.

Vanguard Portfolio Management first reported a position in RCUS in Q1 2026 and has held it in 2 quarters since. 229 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Vanguard Portfolio Management held 4,475,528 shares of Arcus Biosciences worth $138M as of Q2 2026.
  • Vanguard Portfolio Management bought 203,472 Arcus Biosciences shares in Q2 2026, an estimated $5.03M.
  • Arcus Biosciences made up 0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1378 holding.
  • Vanguard Portfolio Management first reported a position in Arcus Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 229 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.